![company](/_next/image?url=%2Flogo-teal-600.png&w=256&q=75)
ADJUTEC PHARMA AS
0379 OSLO
Return on Equity
−62,14 %
Current Ratio
4,06
Debt-to-Equity Ratio
0
Key figures (NOK) | 2022 | |
---|---|---|
Revenue | 7Â 842Â 000 | |
Net Income | −17 151 000 | |
Total Assets | 33Â 992Â 000 | |
Total Equity | 27Â 601Â 000 |
Income (NOK) | 2022 | |
---|---|---|
Revenue | 7Â 842Â 000 | |
Expenditure | 31Â 237Â 000 | |
Operating Profit | −23 395 000 | |
Financial Income | 275Â 000 | |
Financial Costs | 103Â 000 | |
Financial Balance | 172Â 000 | |
Earnings Before Tax | −23 222 000 | |
Tax | −6 072 000 | |
Net Income | −17 151 000 |
Balance (NOK) | 2022 | |
---|---|---|
Total Fixed Assets | 8Â 029Â 000 | |
Total Current Assets | 25Â 963Â 000 | |
Total Assets | 33Â 992Â 000 | |
Total Retained Equity | −21 414 000 | |
Total Equity | 27Â 601Â 000 | |
Total Long-Term Debt | 0 | |
Total Current Debt | 6Â 391Â 000 | |
Total Equity and Debt | 33Â 992Â 000 |
Cash flow (NOK) | 2022 | |
---|---|---|
Sales Income | 0 | |
Other Income | 7Â 842Â 000 | |
Revenue | 7Â 842Â 000 | |
Cost of Goods Sold | 0 | |
Salary Costs | 5Â 157Â 000 | |
Depreciation | 0 | |
Impairment | 0 | |
Expenditure | 31Â 237Â 000 | |
Operating Profit | −23 395 000 | |
Financial Income | 275Â 000 | |
Financial Costs | 103Â 000 | |
Financial Balance | 172Â 000 | |
Dividends | 0 | |
Net Income | −17 151 000 |
Balance details (NOK) | 2022 | |
---|---|---|
Goodwill | 0 | |
Total Intangible Assets | 7Â 954Â 000 | |
Real Eastate | 0 | |
Machinery and Plant Facilities | 0 | |
Fixtures | 0 | |
Total Tangible Assets | 0 | |
Total Fiancial Fixed Assets | 75Â 000 | |
Total Fixed Assets | 8Â 029Â 000 | |
Stock | 0 | |
Total Investments | 0 | |
Cash, Bank | 25Â 638Â 000 | |
Total Current Assets | 25Â 963Â 000 | |
Total Assets | 33Â 992Â 000 | |
Total Equity | 27Â 601Â 000 | |
Short-Term Group Debt | 0 | |
Total Long-Term Debt | 0 | |
Creditors | 7Â 869Â 000 | |
Unpaid Taxes | 407Â 000 | |
Dividends | 0 | |
Other Current Debt | 2Â 865Â 000 | |
Total Current Debt | 6Â 391Â 000 | |
Total Equity and Debt | 33Â 992Â 000 |
Financial indicators | 2022 | |
---|---|---|
Return on Equity | −62,14 % | |
Debt-to-Equity Ratio | 0 | |
Operating Profit Margin | −298,33 % | |
Current Ratio | 4,06 | |
Quick Ratio | 4,06 | |
Equity Ratio | 0,81 | |
Gross Profit Margin | 100Â % |
![Rotate](/_next/image?url=%2Fimages%2Frotate.png&w=48&q=75)